Prologue Medicines
Cambridge
About Prologue Medicines
Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2024)
- Website: prologuemedicines.com
Industries & Categories
Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/prologue-medicines-47552 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.